Herpes Zoster
📧 Sign up to get email alerts when something new happens for Herpes Zoster.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: A Phase 2 Study to Evaluate JCXH-105, an srRNA-based Herpes Zoster Vaccine [Phase 2]
A Phase 2 study is evaluating JCXH-105, an srRNA-based vaccine targeting herpes zoster (shingles), with the trial currently active but not r…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Comprehensive Characterization of Immune Response Induced by Adjuvanted Glycoprotein E (gE)-Based Recombinant VAccine Zoster in Vulnerable Population Receiving ImmunOmodulaNt Therapies
This clinical trial evaluates the immune response to Shingrix (glycoprotein E adjuvanted recombinant zoster vaccine) in vulnerable patients …
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Safety and Immunogenicity of Recombinant Zoster Vaccine for Transplant Recipients [NA]
A clinical trial update evaluating the safety and immunogenicity of the recombinant zoster vaccine in immunosuppressed transplant recipients…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Shingrix in Renal Transplant Recipients [Phase 3]
A Phase 3 clinical trial is recruiting to evaluate the Shingrix vaccine in kidney transplant recipients to assess response and protection ag…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Efficacy of Electroacupuncture for Acute Herpes Zoster-Associated Pain and Biomarker Evaluation [NA]
A clinical trial is evaluating electroacupuncture for pain from acute herpes zoster and biomarker changes; the study is currently recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: A Study to Describe the Safety, Reactogenicity, and Immunogenicity of Herpes Zoster IN001 mRNA Vaccine (IN001) in Healthy Participants [Phase 1]
Phase 1 clinical trial update evaluating the safety, reactogenicity, and immunogenicity of IN001, an mRNA vaccine for herpes zoster, in heal…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell) in Healthy Chinese Population Aged 40 Years and Older [Phase 1, Phase 2]
A Phase 1/2 clinical trial in healthy Chinese adults aged 40 years and older evaluating a recombinant herpes zoster vaccine produced in CHO …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Evaluate the Effect of Recombinant Zoster Vaccine on New Diagnosis of Dementia in an Older Adult Population Aged 76 Years or Older in Finland [Phase 4]
A Phase 4 clinical trial assesses whether the Recombinant Zoster Vaccine influences the incidence of dementia among adults aged 76 and older…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults [Phase 1, Phase 2]
A Pfizer study evaluating a modified RNA vaccine for herpes zoster (shingles) in healthy adults has terminated its Phase 1/2 trial.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: The Analgesic Efficacy and Safety of Venlafaxine for Prevention of Postherpetic Neuralgia in Patients With Acute Herpes Zoster [NA]
This clinical trial assesses whether venlafaxine can prevent postherpetic neuralgia in patients with acute herpes zoster. Recruitment is ong…
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Recombinant Zoster Vaccine in Young Adult Solid Organ Transplant Recipients [Phase 4]
Phase 4 trial update on recombinant zoster vaccine to prevent herpes zoster in young adult solid organ transplant recipients; currently enro…
-
EMA approval · 2026-03-23EMA Authorised: Shingrix (recombinant varicella zoster virus glycoprotein E) — GlaxoSmithKline Biologicals S.A.
The European Medicines Agency authorised Shingrix, a recombinant varicella zoster virus glycoprotein E vaccine by GlaxoSmithKline Biological…
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Safety and Immunogenicity of CVI-VZV-001 in Adults Aged 50 Years and Above [Phase 2]
A Phase 2 clinical trial update assessing the safety and immunogenicity of CVI-VZV-001 in adults aged 50 and older with herpes zoster; the s…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: The Analgesic Efficacy and Safety of Mirogabalin in Patients With Herpes Zoster [NA]
A clinical trial is currently recruiting to evaluate the analgesic efficacy and safety of mirogabalin in patients with herpes zoster.
-
CLINICAL_TRIALS research · 2026-03-10Clinical Trial Update: A Phase III Clinical Trial to Evaluate Long-Term Protective Efficacy of Recombinant Zoster Vaccine (CHO Cell) [Phase 3]
Phase III clinical trial update evaluating the long-term protective efficacy of a recombinant zoster vaccine produced in CHO cells; the stud…
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population [Phase 1, Phase 2]
A clinical trial is assessing safety and immunogenicity of a recombinant varicella zoster vaccine in people with HIV across CD4 strata and a…
-
CLINICAL_TRIALS research · 2026-03-05Clinical Trial Update: Immunogenicity, Efficacy and Safety of Recombinant Herpes Zoster Vaccine in Frail Patients
A recruiting clinical trial is evaluating the immunogenicity, efficacy and safety of a recombinant herpes zoster vaccine in frail, immunocom…
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Zoster Vaccine to Enhance Protection Against Zoster in Solid-organ Transplantation [Phase 2]
A Phase 2 clinical trial evaluating a zoster vaccine to enhance protection against herpes zoster in solid-organ transplant recipients, with …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Study to Test GlaxoSmithKline's (GSK) Candidate Vaccine-GSK1437173A for Prevention of Shingles in Children With Kidney Transplant [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating the safety and immune response of GSK1437173A, GlaxoSmithKline's shingles vaccine candidate, in chi…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: Erector Spinae Plane Block Versus Transcutaneous Radiofrequency in Postherpetic Neuralgia
An ongoing study is recruiting to compare erector spinae plane block with transcutaneous radiofrequency for postherpetic neuralgia. The cond…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: Postherpetic Neuralgia After Herpes Zoster and Incident Dementia Risk
This clinical trial update reports the completion of a study examining the relationship between Herpes Zoster, Postherpetic Neuralgia, and i…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the safety and immunogenicity of a lyophilized herpes zoster virus mRNA vaccine, sponsored by Sinovac …
-
CLINICAL_TRIALS trial_result · 2026-02-05Clinical Trial Update: Shingrix In Recipients of Allogeneic Transplants [Phase 2]
Phase 2 clinical trial evaluating Shingrix in recipients of allogeneic bone marrow or stem cell transplants is currently recruiting. The stu…
-
CLINICAL_TRIALS research · 2026-02-03Clinical Trial Update: Electroacupuncture Regulation of Immune Cells in Herpes Zoster [NA]
A recruiting clinical trial evaluating whether electroacupuncture modulates immune cells in patients with herpes zoster.
-
CLINICAL_TRIALS research · 2026-01-30Clinical Trial Update: The Analgesic Efficacy and Safety of Baclofen in Patients With Herpes Zoster [NA]
A clinical trial is evaluating the analgesic efficacy and safety of baclofen in patients with herpes zoster, and the study is currently recr…